From Casetext: Smarter Legal Research

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
May 3, 2005
MDL Docket No. 1290, Misc. No. 99mc0276 (D.D.C. May. 3, 2005)

Opinion

MDL Docket No. 1290, Misc. No. 99mc0276.

May 3, 2005


ORDER


Pending before the Court is Defendants' Motion to Strike Report on Ratification by Plaintiffs Blue Cross Blue Shield of Massachusetts and Blue Cross Blue Shield of Minnesota ("Motion") [# 814]. Having carefully considered the Motion, Plaintiffs' report on ratification, the representations made by the parties during the emergency hearing that was held on April 27, 2005, and the entire record herein, it is hereby

ORDERED that the Motion [# 814] is denied.

SO ORDERED.


Summaries of

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
May 3, 2005
MDL Docket No. 1290, Misc. No. 99mc0276 (D.D.C. May. 3, 2005)
Case details for

In re Lorazepam Clorazepate Antitrust Litigation

Case Details

Full title:In Re LORAZEPAM CLORAZEPATE ANTITRUST LITIGATION. This Order applies to…

Court:United States District Court, D. Columbia

Date published: May 3, 2005

Citations

MDL Docket No. 1290, Misc. No. 99mc0276 (D.D.C. May. 3, 2005)